Sanofi
Frexalimab
Type 1 Diabetes Mellitus
Countdown
295days
Phase 2 readout · Apr 28, 2027
What's at stake
Phase 2 trial results for Frexalimab in Type 1 Diabetes Mellitus are due Apr 28, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 14h ago
“CT.gov NCT06111586: Phase 2 trial, sponsor Sanofi, drug Frexalimab. Primary completion date 2027-04-28 (estimated).”